QUOTE AND NEWS
Benzinga  Apr 10  Comment 
Extreme Networks Inc. (NASDAQ: EXTR) shares declined 18.21% to $2.65 in pre-market trading after the company lowered its outlook for the third quarter. The company projected an adjusted loss of $0.09 to $0.07 per share, on revenue of $118 million...
Market Intelligence Center  Apr 10  Comment 
A covered call identified by MarketIntelligececenter.com's patented algorithm on Medicines Company (MDCO) could yield about 6.91% (25.73% annualized, for comparison purposes only) in 98 days. Pair a long position in the stock with the Jul. '15...
Benzinga  Apr 1  Comment 
The Medicines Company (NASDAQ: MDCO) today announced that it has settled its litigation with Sun Pharmaceutical Industries Ltd. (Sun Pharma) and certain of its subsidiaries relating to MDCO's U.S. Patent No. 7,582,727 and U.S. Patent No. 7,598,343...
Market Intelligence Center  Mar 30  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with Medicines Company (MDCO) that should provide a 7.57% return in just 109 days. Sell one Jul. '15 call at the $27.00 level for each 100 shares...
Benzinga  Mar 30  Comment 
The Medicines Company today announced that the European Commission has granted marketing authorization for three of its hospital acute care products – KENGREXAL™ (cangrelor), ORBACTIV® (oritavancin), and RAPLIXA™ (sealant powder). These...
Market Intelligence Center  Mar 27  Comment 
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Medicines Company (MDCO) that includes 15.77% downside protection. Sell one contract of the...
Benzinga  Mar 9  Comment 
The Medicines Company (NASDAQ: MDCO) tumbled nearly 10 percent Monday following a court hearing on Friday involving litigation with Hospira, Inc. (NYSE: HSP) over MDCO's Angiomax drug. Opening arguments were expected on Tuesday according to...
Motley Fool  Mar 9  Comment 
A stumble at a competitor raises doubts for The Medicines Company's upcoming FDA decision.
Market Intelligence Center  Feb 25  Comment 
For a hedged play on Medicines Company (MDCO), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Apr. '15 $28.00 covered call for a net debit in the $26.96 area. That is also the break-even stock price for the covered...




RELATED WIKI ARTICLES
 

Based in Parsippany, NJ, The Medicines Company (MDCO) is engaged in acquiring, developing, and marketing specialty pharmaceutical primarily for cardiovascular indications. Its leading product, Angiomax (bivalirudin), which was acquired from Biogen Idec, Inc. in 1996, is used as an anticoagulant in patients undergoing coronary angioplasty. The company's other late-stage products include Clevidipine and Cangrelor, both acquired from AstraZeneca several years ago. Clevidipine is an intravenous drug (calcium channel blocker) intended for the short-term control of blood pressure in patients undergoing cardiac surgery. Cangrelor is an intravenous anticoagulant, having potential uses in coronary angioplasty and cardiac surgery. The company sells its products through its own sales force and distributors. In 2006, sales of Angiomax helped generate $214.0 million revenue.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki